-
Tens of thousands flock to pope's Beirut mass
-
Formula One title showdown: the road to Abu Dhabi
-
Pope Leo holds Beirut mass, visits port blast site
-
Hong Kong leader says independent committee to probe fire
-
How deforestation turbocharged Indonesia's deadly floods
-
New Zealand 231-9 as 'old school' West Indies exploit pace-friendly wicket
-
England spinner Jacks replaces injured Wood for second Ashes Test
-
Pope Leo to hold Beirut mass, visit port blast site
-
Australia opener Khawaja out of second Ashes Test with injury
-
Concern as India orders phone manufacturers to preload govt app
-
French talent Kroupi 'ready to suffer' to realise Premier League dream
-
New Zealand 231-9 as West Indies exploit bowler-friendly wicket
-
US Republicans sweat toss-up election in traditional stronghold
-
'Rescued my soul': Hong Kong firefighters save beloved pets
-
Suns eclipse shoddy Lakers, Mavs upset Nuggets
-
Seven footballers in Malaysia eligibility scandal 'victims': union
-
Patriots on brink of playoffs after Giants rout
-
Survivors, families seek answers to deadly Hong Kong ferry disaster
-
Race to get aid to Asia flood survivors as toll nears 1,200
-
Rugby World Cup draw: who, how and when?
-
Williamson falls for 52 as NZ reach 128-5 in West Indies Test
-
Hong Kong leader announces 'independent committee' to probe fire
-
South Korean leader calls for penalties over e-commerce data leak
-
Samsung unveils first 'special edition' triple-folding phone
-
Apple AI chief leaving as iPhone maker plays catch-up
-
Asian markets rise as US rate cut bets temper Japan bond unease
-
Weight of history against England in pink-ball Gabba Ashes Test
-
How South Korea's brief martial law upended lives
-
VR headsets take war-scarred children to world away from Gaza
-
'We chose it': PKK fighters cherish life in Iraq's mountains
-
US envoy to meet Russia's Putin for talks on ending Ukraine war
-
Pope Leo holds Beirut mass and visits site of port blast
-
'Quad God' Malinin ramps up Olympic preparations at Grand Prix Final
-
New Zealand 17-1 at lunch in rain-hit West Indies Test
-
Pacific island office enabling sanctions-busting 'shadow fleets'
-
White House gets scaled-down Christmas display amid ballroom work
-
GEN Announces New Positive Phase 1 Trial Data of the Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases
-
White House confirms admiral ordered 2nd strike on alleged drug boat
-
Nigeria's defence minister resigns amid security crisis: presidency
-
From Honduras to Poland, Trump meddles in elections as never before
-
Trump holds Venezuela meeting as Maduro rejects 'slave's peace'
-
12 dead, dozens missing as landslide submerges boats in Peru port
-
Vardy's first Serie A double fires Cremonese past high-flying Bologna
-
Rich art: French pastry chefs auction chocolate sculptures
-
Cameroon sack coach Brys, drop goalkeeper Onana for AFCON
-
Son of Mexican crime lord 'El Chapo' pleads guilty in drug case: US media
-
Right-wing rivals for Honduras presidency in 'technical tie'
-
US upbeat on pushing Ukraine deal as envoy heads to Russia
-
European rocket puts S.Korean satellite in orbit
-
Trump to meet top national security team on Venezuela
| RBGPF | 1.54% | 79 | $ | |
| RYCEF | -2.68% | 13.83 | $ | |
| JRI | -0.15% | 13.78 | $ | |
| CMSC | -0.39% | 23.32 | $ | |
| SCS | 0.55% | 16.38 | $ | |
| RIO | 0.03% | 71.97 | $ | |
| AZN | -2.44% | 90.52 | $ | |
| GSK | -1.42% | 47.19 | $ | |
| NGG | -0.61% | 75.65 | $ | |
| BCC | -1.18% | 75.13 | $ | |
| RELX | -1.23% | 39.72 | $ | |
| VOD | -2.8% | 12.13 | $ | |
| CMSD | -0.13% | 23.29 | $ | |
| BTI | -0.91% | 58.13 | $ | |
| BCE | -0.09% | 23.49 | $ | |
| BP | 1.12% | 36.51 | $ |
Ozempic slimming craze sweeps Kosovo despite side effects
Kosovo influencer Tringa Kadriu sees the slimming drug Ozempic as a chance to shed excess pounds -- and she is not the only one in her Balkan nation, where more than half the population is overweight.
"I want to lose 15-16 kilos (33-35 pounds) in two months," Kadriu, 29, told AFP, "and then I'll continue with fitness".
Ozempic, approved in the United States to treat diabetes in 2017, has found an international market for people trying to lose weight.
Despite its cost, the drug has soared in popularity in Kosovo, a country of 1.7 million.
While Kosovo authorities have not sanctioned the drug's use for weight loss, they have noted their limited means to confront use of a drug widely available in the country.
Merita Emini-Sadiku, who heads the Kosovo university hospital's endocrinology clinic, said the cost of the drug had soared.
"The monthly dose used to be 75-80 euros ($85-91), while now it is 130-140 euros ($147-159), probably due to high demand," she said.
But she warned that "Ozempic has side effects that people are not aware of".
Ozempic use can potentially cause issues including thyroid cancer, pancreatitis, gastroparesis and bowel obstruction, according to the latest studies.
- 'Constant demand' -
Meant to treat Type 2 diabetes -- of which the WHO says Kosovo has lower than average levels -- the drug regulates blood sugar levels but also helps suppress hunger, leading to a lower calorie intake.
As a result, its potentially cancerous complications have done little to stem the drug's popularity or availability.
"I checked a lot of pharmacies in Kosovo and I noticed that Ozempic is very easy to get," said Kadriu, adding that pharmacists even suggested she gradually increase her dosage.
A worker at a pharmacy in the capital Pristina's downtown, who asked to remain anonymous, said she had trouble recalling when someone last came into her pharmacy to buy Ozempic with a diabetes prescription.
"But we have a constant demand for Ozempic without a prescription. You can guess why," she said.
Given its availability, Emini-Sadiku said authorities should exercise greater control over Ozempic's distribution.
But Bujar Vitija, a journalist specialising in health, said that would be tricky to achieve given Kosovo's poor health record-keeping.
"Unfortunately there is no data," Vitija said.
With 1,500 to 1,600 private pharmacies in Kosovo, the country's 20 pharmaceutical inspectors have their work cut out for them, he added.
- Ozempic 'every day' -
While Kosovo has lower levels of obesity than the European average, more than 57 percent of the population is overweight and 20 percent is clinically obese, according to a 2019 World Health Organization report.
And women, who are more likely to face societal pressure to be thin, were 66 percent more likely to be obese than men, the WHO report found.
But not every Kosovar who has used Ozempic had the best experience with the drug.
"I took Ozempic on the advice of a doctor for two years but it had no effect," said 48-year-old merchant Lulzim Rrahmani, adding that three of his relatives even experienced "a negative effect of the drug".
"It was just a waste of money and time."
Given the risk of side effects, Emini-Sadiku said Ozempic was "by no means to be taken without a doctor's prescription".
Yet Kadriu said she would not be deterred, adding that she saw colleagues taking the drug "every day at work".
"I don't see any symptom that would deter me."
N.Schaad--VB